Another study33 examined proteomic changes in pancreatic cancer cells stably transfected with eIF5A shRNA or treated with a DHS inhibitor by using one dimensional PAGE and spectral counting method, which does not yield as precise analysis as iTRAQ. Here, EIF5A is linked to pancreatic neoplasm.